Literature DB >> 23529157

Surrogate outcomes in clinical trials: a cautionary tale.

Staffan Svensson1, David B Menkes, Joel Lexchin.   

Abstract

Mesh:

Year:  2013        PMID: 23529157     DOI: 10.1001/jamainternmed.2013.3037

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  32 in total

1.  Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study.

Authors:  Joel Lexchin; Tareq Ahmed
Journal:  CMAJ Open       Date:  2015-07-17

2.  Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?

Authors:  Roojin Habibi; Joel Lexchin; Barbara Mintzes; Anne Holbrook
Journal:  Br J Clin Pharmacol       Date:  2017-08-19       Impact factor: 4.335

3.  The race for drug approvals: hasten slowly?

Authors:  Alain Braillon
Journal:  Eur J Clin Pharmacol       Date:  2018-05-22       Impact factor: 2.953

4.  Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.

Authors:  Elfriede Agyemang; Amalia S Magaret; Stacy Selke; Christine Johnston; Larry Corey; Anna Wald
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

5.  Failing to improve overall survival because post-protocol survival is long: fact, myth, excuse or improper study design?

Authors:  Vinay Prasad; Andrae Vandross
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-29       Impact factor: 4.553

Review 6.  The reversal of cardiology practices: interventions that were tried in vain.

Authors:  Vinay Prasad; Adam Cifu
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

7.  An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis.

Authors:  Karine E Manera; Allison Tong; Jonathan C Craig; Jenny Shen; Shilpa Jesudason; Yeoungjee Cho; Benedicte Sautenet; Armando Teixeira-Pinto; Martin Howell; Angela Yee-Moon Wang; Edwina A Brown; Gillian Brunier; Jeffrey Perl; Jie Dong; Martin Wilkie; Rajnish Mehrotra; Roberto Pecoits-Filho; Saraladevi Naicker; Tony Dunning; Nicole Scholes-Robertson; David W Johnson
Journal:  Kidney Int       Date:  2019-03-29       Impact factor: 10.612

Review 8.  Confounding biases in studies on early- versus late-caffeine in preterm infants: a systematic review.

Authors:  Sandra Nylander Vujovic; Chiara Nava; Minna Johansson; Matteo Bruschettini
Journal:  Pediatr Res       Date:  2020-01-13       Impact factor: 3.756

Review 9.  From evidence to best practice in laboratory medicine.

Authors:  A Rita Horvath
Journal:  Clin Biochem Rev       Date:  2013-08

Review 10.  Biomarkers and surrogate endpoints in glaucoma clinical trials.

Authors:  Felipe A Medeiros
Journal:  Br J Ophthalmol       Date:  2014-07-17       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.